Quarterly report · Q1
6323.TEDINET S100RDKZ
Period2023-03-01 → 2023-05-31
Filed2023-07-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.7bn | 2023-03-01 → 2023-05-31 | Cons. | Net sales |
| Revenue | ¥94.5bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.7bn | 2022-03-01 → 2022-05-31 | Cons. | Net sales |
| Operating income | ¥4.7bn | 2023-03-01 → 2023-05-31 | Cons. | Operating income |
| Operating income | ¥5.0bn | 2022-03-01 → 2022-05-31 | Cons. | Operating income |
| Ordinary income | ¥5.2bn | 2023-03-01 → 2023-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥30.3bn | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.2bn | 2022-03-01 → 2022-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥5.2bn | 2023-03-01 → 2023-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥7.2bn | 2022-03-01 → 2022-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.6bn | 2023-03-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.4bn | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.1bn | 2022-03-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.7bn | 2023-03-01 → 2023-05-31 | Cons. | Profit loss |
| Net income | ¥5.4bn | 2022-03-01 → 2022-05-31 | Cons. | Profit loss |
| Total assets | ¥140.4bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥126.5bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥100.5bn | at 2022-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥60.3bn | at 2023-05-31 | Cons. | Liabilities |
| Total liabilities | ¥51.7bn | at 2023-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥80.1bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥74.8bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥55.7bn | at 2022-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥33.3bn | at 2023-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥28.3bn | at 2023-02-28 | Cons. | Cash and deposits |
| EPS (basic) | ¥201.91 | 2023-03-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,237.42 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥296.64 | 2022-03-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥201.54 | 2023-03-01 → 2023-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥1,235.1 | 2022-03-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥296.08 | 2022-03-01 → 2022-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 52.4% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.9% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-05-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-05-31 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-05-31 | −¥118m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥100m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥100m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | segment profit | 2023-03-01 → 2023-05-31 | −¥62m |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥16.6bn |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥16.6bn |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥2m |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥4.9bn |
| —segment total | revenue | 2023-03-01 → 2023-05-31 | ¥16.7bn |
| —segment total | revenue external | 2023-03-01 → 2023-05-31 | ¥16.7bn |
| —segment total | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥2m |
| —segment total | segment profit | 2023-03-01 → 2023-05-31 | ¥4.8bn |
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2022-05-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2022-05-31 | −¥101m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥44m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥44m |
| jpcrp040300-q1r_E02328-000Life Sciencereportable segment | segment profit | 2022-03-01 → 2022-05-31 | −¥76m |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue | 2022-03-01 → 2022-05-31 | ¥21.6bn |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue external | 2022-03-01 → 2022-05-31 | ¥21.6bn |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥0 |
| jpcrp040300-q1r_E02328-000Semiconductor And FPDreportable segment | segment profit | 2022-03-01 → 2022-05-31 | ¥5.2bn |
| —segment total | revenue | 2022-03-01 → 2022-05-31 | ¥21.7bn |
| —segment total | revenue external | 2022-03-01 → 2022-05-31 | ¥21.7bn |
| —segment total | revenue intersegment | 2022-03-01 → 2022-05-31 | ¥0 |
| —segment total | segment profit | 2022-03-01 → 2022-05-31 | ¥5.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 357
| Item | Context | Value | Unit |
|---|---|---|---|
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes business combinations quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |